Expert Perspectives.

Slides:



Advertisements
Similar presentations
Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.
Advertisements

Diabetic Dyslipidemia in Practice
Selection of NSAIDs for Osteoarthritis
Preventing Thrombotic Complications in ACS: State of the Art
Monitoring and Management of Adult Relapsed/Refractory Acute Promyelocytic Leukemia.
NOACs for Cancer-Associated Thrombosis:
Current Dyslipidemia Management Guidelines Residual Risk.
Atrial Fibrillation and PCI
Optimizing Therapy for Osteoarthritis
New Data on the Safety of SGLT2 Inhibitors
US Guidelines US Guidelines Low-risk Patients.
Achieving Long-Term Protection Post-MI
When Is Adding Aspirin to NOACs Worth the Risk?
Emerging Data on ACS Management From ACC
A New Era for NOACs:.
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Updates on Outcomes for Novel T2D Therapies
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Update on NSAID Use:.
Antithrombotics and PAD: A New Paradigm in Practice
New Perspectives in CAD and PAD: Weighing the Latest Evidence
Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.
Beyond Statin Therapy.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
SGLT2 Inhibitors and CV Outcomes
Antiplatelet Therapy and Secondary Prevention
The Evolving Role of Immunotherapy in NSCLC
Stroke and AF.
A Unified Approach to Anticoagulant Therapy in ACS: What's Missing?
Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?
Managing gBRCA-Positive Metastatic Breast Cancer
Evaluating LDL-C Recommendations
A Journal Club on Lipid Management:
PCSK9 Inhibitors and Cardiovascular Outcomes
Learning Objectives Classification of VTE Goals of VTE Treatment.
Gene Therapy: Past, Present, and Future
PCSK9 Inhibitors – A Leap in the Evolution of Dyslipidemia Management?
OTC NSAID Use in Patients With OA and CV Disease
EXAMINE Study: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome.
Diagnosing Focal Epilepsy: A Clinical Case
Treatment of Thromboembolic Disease The Need for Multiple Perspectives
Learning Objectives Metabolic Abnormalities Associated With T2D.
WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?
Expert Perspectives on New Data in Multiple Sclerosis From the 2018 European MS Meeting.
Factor Xa Inhibitors in PAD
Scientific Update.
Case Challenges: Early and Intensive Type 2 Diabetes Treatment With Modern Agents.
Patient-Centered Management in BRAF-Positive Metastatic Melanoma
Typical Patient Presentation
Insulin in Diabetes Management: Effective Patient Selection Is Key
Optimizing Joint Health in Hemophilia
Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial
Program Goals Background: Anticoagulation in Patients With VTE.
Improving Overall Health
Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.
Treating Osteoarthritis
Managing Pain in the 21st Century
What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.
Optimizing Treatment of Refractory Gout
Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?
Emerging Advances in Reducing Renal Complications of T2D
Anemia Explored.
Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.
BRIDGING CVD AND T2DM: LESSONS LEARNED FROM OUTCOME TRIALS
Top Tips in Evidence-Based Care for HFrEF
Comparative Studies of Biologics in Ulcerative Colitis
Rethinking Risk Stratification for Nonischemic HF:
Biosimilars in Immune-Related Diseases
The Power of As-Treated Analyses
Presentation transcript:

Expert Perspectives

Concerns With NSAIDs

NSAID Influence on Risk of CV AEs

NSAID Influence on Risk of CV AEs (cont)

Classification of NSAIDs

PRECISION Trial Knowledge Gaps in CV Safety and NSAIDs

PRECISION Trial Study Limitations and Results

Outcomes of NSAID Meta-Analyses Any Differences in CV Safety Among the NSAIDs?

Outcomes of NSAID Systemic Reviews

Implications for Clinical Practice A Look at Aspirin

Implications for Clinical Practice 2014 AHA/ACC NSTE-ACS Guidelines for NSAID Use

Concluding Remarks

Concluding Remarks (cont)

Abbreviations